Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 3/2009

01.03.2009 | Article

Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study

verfasst von: C. León, F. Álvarez-Lerma, S. Ruiz-Santana, M. Á. León, J. Nolla, R. Jordá, P. Saavedra, M. Palomar, The EPCAN Study Group

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this paper is to determine the incidence of fungal colonization and infection in non-neutropenic critically ill patients and to identify factors favoring infection by Candida spp. A total of 1,655 consecutive patients (>18 years of age) admitted for ≥7 days to 73 medical-surgical Spanish intensive care units (ICUs) participated in an observational prospective cohort study. Surveillance samples were obtained once a week. One or more fungi were isolated in different samples in 59.2% of patients, 94.2% of which were Candida spp. There were 864 (52.2%) patients with Candida spp. colonization and 92 (5.5%) with proven Candida infection. In the logistic regression analysis risk factors independently associated with Candida spp. infection were sepsis (odds ratio [OR] = 8.29, 95% confidence interval [CI] 5.07–13.6), multifocal colonization (OR = 3.49, 95% CI 1.74–7.00), surgery (OR = 2.04, 95% CI 1.27–3.30), and the use of total parenteral nutrition (OR = 4.37, 95% CI 2.16–8.33). Patients with Candida spp. infection showed significantly higher in-hospital and intra-ICU mortality rates than those colonized or non-colonized non-infected (P < 0.001). Fungal colonization, mainly due to Candida spp., was documented in nearly 60% of non-neutropenic critically ill patients admitted to the ICU for more than 7 days. Proven candidal infection was diagnosed in 5.5% of cases. Risk factors independently associated with Candida spp. infection were sepsis, multifocal colonization, surgery, and the use of total parenteral nutrition.
Literatur
1.
Zurück zum Zitat Beck-Sagué CM, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 167:1247–1251PubMed Beck-Sagué CM, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 167:1247–1251PubMed
2.
Zurück zum Zitat Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526–1530PubMed Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526–1530PubMed
4.
Zurück zum Zitat Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA (1998) International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY Program. The SENTRY Participant Group. J Clin Microbiol 36:1886–1889PubMed Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA (1998) International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY Program. The SENTRY Participant Group. J Clin Microbiol 36:1886–1889PubMed
5.
Zurück zum Zitat Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644. doi:10.1001/jama.274.8.639 PubMedCrossRef Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644. doi:10.​1001/​jama.​274.​8.​639 PubMedCrossRef
6.
Zurück zum Zitat Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA et al (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186. doi:10.1086/321811 PubMedCrossRef Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA et al (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186. doi:10.​1086/​321811 PubMedCrossRef
7.
Zurück zum Zitat Álvarez-Lerma F, Palomar M, Olaechea P, Otal JJ, Insausti J, Cerdá E; Grupo de Estudio de Vigilacia de Infección Nosocomial en UCI (2007) National Study of Control of Nosocomial Infection in Intensive Care Units. Evolutive report of the years 2003–2005. Med Intensiva 31:6–17PubMedCrossRef Álvarez-Lerma F, Palomar M, Olaechea P, Otal JJ, Insausti J, Cerdá E; Grupo de Estudio de Vigilacia de Infección Nosocomial en UCI (2007) National Study of Control of Nosocomial Infection in Intensive Care Units. Evolutive report of the years 2003–2005. Med Intensiva 31:6–17PubMedCrossRef
8.
Zurück zum Zitat Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J et al (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206–216. doi:10.1007/s001340050552 PubMedCrossRef Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J et al (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206–216. doi:10.​1007/​s001340050552 PubMedCrossRef
9.
Zurück zum Zitat Álvarez-Lerma F, Palomar M, León C, Olaechea P, Cerdá E, Bermejo B; Grupo de Estudio de Infeción Fúngica (2003) Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients. Med Clin (Barc) 121:161–166. doi:10.1157/13049416 CrossRef Álvarez-Lerma F, Palomar M, León C, Olaechea P, Cerdá E, Bermejo B; Grupo de Estudio de Infeción Fúngica (2003) Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients. Med Clin (Barc) 121:161–166. doi:10.​1157/​13049416 CrossRef
12.
Zurück zum Zitat Álvarez-Lerma F, Nolla-Salas J, León C, Palomar M, Jordá R, Carrasco N et al; EPCAN Study Group (2003) Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 29:1069–1076. doi:10.1007/s00134-003-1807-y PubMedCrossRef Álvarez-Lerma F, Nolla-Salas J, León C, Palomar M, Jordá R, Carrasco N et al; EPCAN Study Group (2003) Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 29:1069–1076. doi:10.​1007/​s00134-003-1807-y PubMedCrossRef
13.
Zurück zum Zitat American College of Chest Physicians/Society of Critical Care Medicine (1992) Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef American College of Chest Physicians/Society of Critical Care Medicine (1992) Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
14.
Zurück zum Zitat Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41(RR-17):1–19 Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41(RR-17):1–19
15.
Zurück zum Zitat Hurst JW, Morris DC, Alexander RW (1999) The use of the New York Heart Association’s classification of cardiovascular disease as part of the patient’s complete Problem List. Clin Cardiol 22:385–390PubMedCrossRef Hurst JW, Morris DC, Alexander RW (1999) The use of the New York Heart Association’s classification of cardiovascular disease as part of the patient’s complete Problem List. Clin Cardiol 22:385–390PubMedCrossRef
17.
Zurück zum Zitat Petri MG, König J, Moecke HP, Gramm HJ, Barkow H, Kujath P et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 23:317–325. doi:10.1007/s001340050334 PubMedCrossRef Petri MG, König J, Moecke HP, Gramm HJ, Barkow H, Kujath P et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 23:317–325. doi:10.​1007/​s001340050334 PubMedCrossRef
19.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821. doi:10.1086/588660 PubMedCrossRef De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821. doi:10.​1086/​588660 PubMedCrossRef
20.
21.
Zurück zum Zitat Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg D et al (2008) Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46:1206–1213. doi:10.1086/529435 PubMedCrossRef Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg D et al (2008) Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46:1206–1213. doi:10.​1086/​529435 PubMedCrossRef
22.
23.
Zurück zum Zitat Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ et al; SENTRY Participant Group (2001) International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 39:3254–3259. doi:10.1128/JCM.39.9.3254-3259.2001 PubMedCrossRef Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ et al; SENTRY Participant Group (2001) International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 39:3254–3259. doi:10.​1128/​JCM.​39.​9.​3254-3259.​2001 PubMedCrossRef
25.
Zurück zum Zitat Diaz E, Villagrá A, Rello J, Vallés J; Grupo de Estudio de Bacteriemias en ICU (1999) Factores de riesgo de candidemia nosocomial en cuidados intensivos. Med Intensiva 23:25–31 Diaz E, Villagrá A, Rello J, Vallés J; Grupo de Estudio de Bacteriemias en ICU (1999) Factores de riesgo de candidemia nosocomial en cuidados intensivos. Med Intensiva 23:25–31
26.
Zurück zum Zitat Karabinis A, Hill C, Leclercq B, Tancrède C, Baume D, Andremont A (1988) Risk factors for candidemia in cancer patients: a case–control study. J Clin Microbiol 26:429–432PubMed Karabinis A, Hill C, Leclercq B, Tancrède C, Baume D, Andremont A (1988) Risk factors for candidemia in cancer patients: a case–control study. J Clin Microbiol 26:429–432PubMed
27.
Zurück zum Zitat Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 15:414–421PubMed Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 15:414–421PubMed
29.
30.
Zurück zum Zitat Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717. doi:10.1007/s00134-002-1540-y PubMedCrossRef Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717. doi:10.​1007/​s00134-002-1540-y PubMedCrossRef
31.
Zurück zum Zitat León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Álvarez-Lerma F et al; EPCAN Study Group (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737. doi:10.1097/01.CCM.0000202208.37364.7D PubMedCrossRef León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Álvarez-Lerma F et al; EPCAN Study Group (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737. doi:10.​1097/​01.​CCM.​0000202208.​37364.​7D PubMedCrossRef
32.
Zurück zum Zitat Pittet D, Li N, Wenzel RP (1993) Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur J Clin Microbiol Infect Dis 12:813–819. doi:10.1007/BF02000400 PubMedCrossRef Pittet D, Li N, Wenzel RP (1993) Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur J Clin Microbiol Infect Dis 12:813–819. doi:10.​1007/​BF02000400 PubMedCrossRef
Metadaten
Titel
Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study
verfasst von
C. León
F. Álvarez-Lerma
S. Ruiz-Santana
M. Á. León
J. Nolla
R. Jordá
P. Saavedra
M. Palomar
The EPCAN Study Group
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0618-z

Weitere Artikel der Ausgabe 3/2009

European Journal of Clinical Microbiology & Infectious Diseases 3/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.